Preclinical studies of the PARP inhibitor olaparib in combination with imatinib in BRCA stratified ovarian cancer

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Matheson E, Salehan M, Mukhopadhyay A, Curtin NJ, Drew Y

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 16th Biennial Meeting of the International Gynecologic Cancer Society

Year of Conference: 2016

Pages: 673-673

Print publication date: 01/10/2016

Acceptance date: 02/04/2016

ISSN: 1048-891X

Publisher: Lippincott Williams & Wilkins, Ltd.

URL: https://doi.org/10.1097/01.IGC.0000503327.50238.5c

DOI: 10.1097/01.IGC.0000503327.50238.5c

Series Title: International Journal of Gynecological Cancer

ePrints